True Wealth Design’s Genmab GMAB Stock Holding History

True Wealth Design’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.72K	Sell	281 -10	-3%	-$266	﹤0.01%	1166
2026 Q1	$7.81K	Hold	291	–	–	﹤0.01%	1054
2025 Q4	$8.96K	Sell	291 -2	-0.7%	-$62	﹤0.01%	902
2025 Q3	$8.99K	Buy	293 +243	+486%	+$5.92K	﹤0.01%	875
2025 Q2	$1.03K	Buy	50 +18	+56%	+$369	﹤0.01%	1447
2025 Q1	$627	Buy	32 +14	+78%	+$294	﹤0.01%	1457
2024 Q4	$376	Sell	18 -5	-22%	-$110	﹤0.01%	1139
2024 Q3	$561	Hold	23	–	–	﹤0.01%	1082
2024 Q2	$578	Buy	23 +3	+15%	+$85	﹤0.01%	627
2024 Q1	$599	Buy	20 +6	+43%	+$176	﹤0.01%	589
2023 Q4	$446	Hold	14	–	–	﹤0.01%	496
2023 Q3	$494	Hold	14	–	–	﹤0.01%	431
2023 Q2	$533	Hold	14	–	–	﹤0.01%	423
2023 Q1	$529	Hold	14	–	–	﹤0.01%	512
2022 Q4	$593	Buy	+14	New	+$577	﹤0.01%	424

Other funds holding GMAB

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

True Wealth Design's GMAB Position: Q2 2026 in Review

True Wealth Design reduced its Genmab (GMAB) stake by 3.4% in Q2 2026, selling an estimated $266 and leaving 281 shares worth $7.72K. The position accounts for ﹤0.01% of the portfolio, ranked #1166.

True Wealth Design first reported a position in GMAB in Q4 2022 and has held it in 15 quarters since. The position peaked at $8.99K in Q3 2025. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

True Wealth Design held 281 shares of Genmab worth $7.72K as of Q2 2026.
True Wealth Design sold 10 Genmab shares in Q2 2026, an estimated $266.
Genmab made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1166 holding.
True Wealth Design first reported a position in Genmab in Q4 2022 and has held it in 15 quarters since.
True Wealth Design's Genmab position peaked at $8.99K in Q3 2025.
289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.